rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5-6
|
pubmed:dateCreated |
2003-10-31
|
pubmed:abstractText |
Recent studies indicate that adiponectin may have anti-inflammatory and anti-atherogenic properties, suggesting that hypoadiponectinemia can play a role in the pathogenesis of cardiovascular disease. Therefore the aim of the study was to assess plasma adiponectin concentration in hypertensive male patients with coronary artery disease (CAD). Associations of adiponectinemia with other cardiovascular risk factors were also analysed.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0049-3848
|
pubmed:author |
pubmed-author:DemkowMarcinM,
pubmed-author:Dzieli?skaZofiaZ,
pubmed-author:FlorczakElzbietaE,
pubmed-author:JanasJadwigaJ,
pubmed-author:JanuszewiczAndrzejA,
pubmed-author:JanuszewiczMagdalenaM,
pubmed-author:KadzielaJacekJ,
pubmed-author:Makowiecka-Cie?laMagdalenaM,
pubmed-author:MielniczukRyszardR,
pubmed-author:PrejbiszAleksanderA,
pubmed-author:Ruzy??oWitoldW,
pubmed-author:WiecekAndrzejA
|
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
110
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
365-9
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:14592564-Adiponectin,
pubmed-meshheading:14592564-Adult,
pubmed-meshheading:14592564-Aged,
pubmed-meshheading:14592564-Anti-Inflammatory Agents,
pubmed-meshheading:14592564-Comorbidity,
pubmed-meshheading:14592564-Coronary Artery Disease,
pubmed-meshheading:14592564-Humans,
pubmed-meshheading:14592564-Hypertension,
pubmed-meshheading:14592564-Intercellular Signaling Peptides and Proteins,
pubmed-meshheading:14592564-Male,
pubmed-meshheading:14592564-Middle Aged,
pubmed-meshheading:14592564-Poland,
pubmed-meshheading:14592564-Proteins,
pubmed-meshheading:14592564-Risk Assessment,
pubmed-meshheading:14592564-Risk Factors
|
pubmed:year |
2003
|
pubmed:articleTitle |
Decreased plasma concentration of a novel anti-inflammatory protein--adiponectin--in hypertensive men with coronary artery disease.
|
pubmed:affiliation |
Department of Coronary Heart Disease, Institute of Cardiology, Alpejska 42, 04-628 Warsaw, Poland.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Controlled Clinical Trial,
Research Support, Non-U.S. Gov't
|